293 related articles for article (PubMed ID: 9870856)
21. Glycogen-rich pleomorphic xanthoastrocytoma with clear-cell features: confirmatory report of a rare variant with implications for differential diagnosis.
Vajtai I; Stibal A; von Gunten M; Kappeler A; Vassella E; Frank S
Pathol Res Pract; 2011 Apr; 207(4):256-61. PubMed ID: 21282017
[TBL] [Abstract][Full Text] [Related]
22. Pleomorphic xanthoastrocytoma: what do we really know about it?
Giannini C; Scheithauer BW; Burger PC; Brat DJ; Wollan PC; Lach B; O'Neill BP
Cancer; 1999 May; 85(9):2033-45. PubMed ID: 10223246
[TBL] [Abstract][Full Text] [Related]
23. Pleomorphic xanthoastrocytoma: report of 5 cases.
Heyerdahl Strøm E; Skullerud K
Clin Neuropathol; 1983; 2(4):188-91. PubMed ID: 6652992
[TBL] [Abstract][Full Text] [Related]
24. Subependymal giant cell astrocytoma: a clinicopathologic study with HMB45 and MIB-1 immunohistochemical analysis.
Gyure KA; Prayson RA
Mod Pathol; 1997 Apr; 10(4):313-7. PubMed ID: 9110292
[TBL] [Abstract][Full Text] [Related]
25. [Pleomorphic xanthoastrocytoma (Kepes): a case report].
Bukeo T; Nakamura S; Nishimoto A; Tabuchi K
No Shinkei Geka; 1985 Jul; 13(7):773-7. PubMed ID: 4047323
[TBL] [Abstract][Full Text] [Related]
26. Correlation of glial fibrillary acidic protein (GFAP) with grading of the neuroglial tumours.
Reyaz N; Tayyab M; Khan SA; Siddique T
J Coll Physicians Surg Pak; 2005 Aug; 15(8):472-5. PubMed ID: 16202357
[TBL] [Abstract][Full Text] [Related]
27. Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort.
Pollack IF; Hamilton RL; Burnham J; Holmes EJ; Finkelstein SD; Sposto R; Yates AJ; Boyett JM; Finlay JL
Neurosurgery; 2002 Jun; 50(6):1238-44; discussion 1244-5. PubMed ID: 12015841
[TBL] [Abstract][Full Text] [Related]
28. Significance of cyclin D1 expression in meningiomas: a preliminary study.
Alama A; Barbieri F; Spaziante R; Bruzzo C; Dadati P; Dorcaratto A; Ravetti JL
J Clin Neurosci; 2007 Apr; 14(4):355-8. PubMed ID: 17240151
[TBL] [Abstract][Full Text] [Related]
29. [A case of pleomorphic xanthoastrocytoma].
Ibayashi N; Kubo S; Sekimoto T; Takemi K; Ikeda M
No To Shinkei; 1986 Dec; 38(12):1151-5. PubMed ID: 3814441
[TBL] [Abstract][Full Text] [Related]
30. Subependymal giant cell astrocytoma: a clinicopathological study of 23 cases with special emphasis on proliferative markers and expression of p53 and retinoblastoma gene proteins.
Sharma M; Ralte A; Arora R; Santosh V; Shankar SK; Sarkar C
Pathology; 2004 Apr; 36(2):139-44. PubMed ID: 15203749
[TBL] [Abstract][Full Text] [Related]
31. The evolution of the histology in pleomorphic xanthoastrocytomas in children: a study of 15 cases.
Wu X; Bandopadhayay P; Ng J; Ashley D; Chow CW
Pathology; 2011 Jan; 43(1):9-16. PubMed ID: 21240059
[TBL] [Abstract][Full Text] [Related]
32. Prognostic relevance of MIB-1 immunoreactivity, S-phase fraction, 5-bromo-2'-deoxyuridine labeling indices, and mitotic figures in gliomas.
Struikmans H; Rutgers DH; Jansen GH; Dullens HF; Oosten L; Tulleken CA; van der Tweel I; Battermann JJ
Radiat Oncol Investig; 1999; 7(4):243-8. PubMed ID: 10492165
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade.
Nakamura N; Yamamoto H; Yao T; Oda Y; Nishiyama K; Imamura M; Yamada T; Nawata H; Tsuneyoshi M
Hum Pathol; 2005 Jul; 36(7):828-37. PubMed ID: 16084954
[TBL] [Abstract][Full Text] [Related]
34. Pleomorphic xanthoastrocytoma: DNA flow cytometry and outcome analysis of 12 patients.
Rostomily RC; Hoyt JW; Berger MS; Kros JM; Alvord EC; Wilkins P; Rabinovitch P
Cancer; 1997 Dec; 80(11):2141-50. PubMed ID: 9392337
[TBL] [Abstract][Full Text] [Related]
35. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
36. Prognostic relevance of p53 alterations and Mib-1 proliferation index in subgroups of primary liposarcomas.
Schneider-Stock R; Ziegeler A; Haeckel C; Franke DS; Rys J; Roessner A
Clin Cancer Res; 1999 Oct; 5(10):2830-5. PubMed ID: 10537349
[TBL] [Abstract][Full Text] [Related]
37. [Clinicopathologic study of pleomorphic xanthoastrocytoma of brain].
Li NY; Zhou J; Zhou HB; Ma HH
Zhonghua Bing Li Xue Za Zhi; 2006 Aug; 35(8):453-7. PubMed ID: 17069696
[TBL] [Abstract][Full Text] [Related]
38. Expression of the CD34 antigen in pleomorphic xanthoastrocytomas.
Reifenberger G; Kaulich K; Wiestler OD; Blümcke I
Acta Neuropathol; 2003 Apr; 105(4):358-64. PubMed ID: 12624789
[TBL] [Abstract][Full Text] [Related]
39. Pleomorphic xanthoastrocytoma in elderly patients may portend a poor prognosis.
Ng WH; Lim T; Yeo TT
J Clin Neurosci; 2008 Apr; 15(4):476-8. PubMed ID: 18255294
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas.
Amatya VJ; Takeshima Y; Sugiyama K; Kurisu K; Nishisaka T; Fukuhara T; Inai K
Hum Pathol; 2001 Sep; 32(9):970-5. PubMed ID: 11567227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
